Francesco Bibbiani

Statistics

Publications

Citations

2.1K

H-Index

Active since

2001

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

Eisai (United States)

National Institutes of Health

Eisai (United Kingdom)

Central Michigan University

Francesco Bibbiani is an author at National Institute of Neurological Disorders and Stroke specializing in pharmacology, medicine, and neuropharmacology.

ORCID

Publications per year

2001–2021

Publications

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy

Jacqueline A. French, Gregory L. Krauss, Robert Wechsler et al. · Neurology · 2015 · 330 citations · Full text

Medicine, Neurology, Pharmacology +14

Adenosine A <sub>2A</sub> receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

Medicine, Pharmacology, Pharmacotherapy +17

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Francesco Bibbiani, Justin D. Oh, Thomas N. Chase · Neurology · 2001 · 239 citations

Medicine, Neuroscience, Pharmacology +17

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease

Francesco Bibbiani, Justin D. Oh, Jacobus P. Petzer et al. · Experimental Neurology · 2003 · 204 citations

Medicine, Neuroscience, Pharmacology +14

Effects of serotonin 5‐HT1A agonist in advanced Parkinson's disease

William Bara‐Jimenez, Francesco Bibbiani, Michael J. Morris et al. · Movement Disorders · 2005 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 19